Intima Bioscience, Inc.
https://www.intimabioscience.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Intima Bioscience, Inc.
Ex-Novartis Oncology Leader Riva Takes On Challenge Of Transgene Turnaround
After AstraZeneca walked away from a oncolytic virus vaccine partnership in May, French biotech Transgene was in sore need of a new direction. Enter new CEO Alessandro Riva, a man determined to deliver a proof of concept for the company.
Deal Watch: Amgen Taps Plexium's Expertise In Targeted Protein Degradation
Mersana will help J&J develop antibody-drug conjugates against three targets, while AstraZeneca out-licenses a candidate for peripheral artery disease to Regio.
Company Information
- Industry
- Biotechnology
-
Biotechnology
- Gene Therapy, Cell Therapy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Intima Bioscience, Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice